SOURCE: GeneThera, Inc.

September 21, 2006 13:16 ET

Update: GeneThera, Inc., Willingham to Unveil Analysts Report on MN1.com

DALLAS, TX -- (MARKET WIRE) -- September 21, 2006 -- Dr. Antonio Milici M.D., Ph.D., 51, CEO of GeneThera, Inc., will appear live on Market News First Friday, September 22, at 11:30 AM CDT with MN1.com premier analyst, Michael Willingham, to discuss Willingham's analyst report of the company. The two will also field questions from those who have been following GeneThera, Inc. (OTCBB: GTHA) and the market in general.

The live, exclusive discussion will be on MN1.com, and is available to anyone with internet access and who can download the free player at www.MN1.com.

GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA™, a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GEA™ is designed for a host of individual diseases, the current priority being Mad Cow Disease, Chronic Wasting Disease, a disease affecting elk and deer in North America; E.Coli 0157:H7 and Johnne's Disease, diseases affecting cattle worldwide. The company is currently focusing on the two molecular laboratories they are planning to open outside the US to treat cattle for mad cow disease and Johnne's disease. GeneThera has an agreement with Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna to collaborate on scientific research related to the diagnosis of animal transmittable diseases, such as Mad Cow Disease and Scrapie. The other lab will be located in Mexico where they will be focusing on Johnne's disease.

About Michael Willingham:

Market News First analyst Michael A. Willingham has covered four microcap companies and has hosted his detailed reports on www.MN1.com. Global Beverage Solutions is a beverage focused business development company traded on the OTC Bulletin Board; USN Corp. is another OTC Bulletin Board company and broadcasts its Ultimate Shopping Network to roughly 30 million Americans; National Storm Management trades on the Pink Sheets market and is directly focused on storm restoration services in areas hardest hit by frequent natural disasters; and Microtrak is in the telematics industry with a significant pipeline of promising projects with projected year-over- year revenue increase of over 600 percent.

Since Mike's initial coverage of GBVS, the stock has traded higher by over 168 percent. USNR is up seven percent, NLST has gained nearly 16 percent, and MIOK has risen almost 24 percent since coverage was initiated. The nominal average increase in price is over 53 percent, while the weighted average increase for these four stocks is 36 percent. For a complete biography on Willingham, go to http://www.mn1.com/special_reports.html.

About Market News First:

Being the only online destination that brings real blow-by-blow information and analysis on micro-cap news, MN1.com features live press conferences, live interviews and exclusive investment news. MN1.com gives micro-cap investors the information source necessary to trade in the markets. MN1.com boasts being the largest true news company reporting on micro-cap traded stocks.

In addition to live interaction with companies from the Bulletin Board, Pink Sheets and Amex, MN1 has All-Day Live Trading Commentary, Analyst Profiles, Interactive Forums, News Items and The MicroBlog. MN1 Blog features opinions, thoughts and comments of Michael A. Willingham and Andrew Coffee along with other participants giving the latest on micro-cap invests and trends.

Market News First will turn the average investor into a more decisive, profitable investor, by answering micro-cap investors' questions before they are even asked.

Contact Information